Cart

Personal Human lmmune System Mice: Accelerating the Translation of lmmuno-therapies from Bench to Bedside

Register Link:

https://www.eventbrite.com/e/genobiotx-february-2025-webinar-tickets-1228646116609?aff=oddtdtcreator

Date:

  • Wednesday, Feb. 26th, 2025; 2:00 pm EST or 11:00 am PST

Meet Our Speaker:

Dr. Huang earned a Ph.D. in 2004 from the Institute of Zoology, Chinese Academy of Sciences, followed by a postdoctoral fellowship at Peking University Health Science Center (2004–2006). Dr. Huang has dedicated over 15 years to groundbreaking research in the United States at prestigious institutions, including Albert Einstein College of Medicine, the Aaron Diamond AIDS Research Center, Rockefeller University, and Columbia University. A member of Sigma Xi, the Genetics Society of America, and the American Geriatrics Society, Dr. Huang has authored more than 30 peer-reviewed papers in esteemed journals such as Science Translational Medicine and Frontiers in Immunology. Their research focuses on tumor immunology, vaccines, infectious diseases, and animal model development. In 2019, Dr. Huang] founded Genomab Biotech (www.genomab.com) in New York, where they serve as CEO. In 2021, they further expanded their vision by establishing NexVivo Biotech in Suzhou, China, advancing innovation in the biotech industry globally.

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

Watch Video

    News Center

    Join Our Webinar: Applications of Humanized Mouse Models in Preclinical Research

    Webinars

    Join our webinar on July 25th for an introduction and background on humanized mouse models, focusing on their effective applications in preclinical research for advancing targeted therapies across diseases. Date: Thursday, July 25th, 2024; 2:00 pm EDT or 11:00 am PDT Webinar Highlights: Introduction to humanized mouse models for preclinical research developed by GenoBioTX Discover […]

    CCR8: the Next Promising Immune Checkpoint for Antitumor Drugs Development

    Blogs

    CCR8, as a novel immune checkpoint in tumor microenvironment, was hotly discussed during 2022 AACR conference. Since then, numerous prestigious pharmaceutical corporations have shifted their attention to CCR8, previously almost unknown. You may wonder why CCR8 gave rise to so strong interest of pharmaceutical industry. Just follow us to have a quick review of CCR8, […]

    Email Back to top